GlyT1 (SLC6A9) inhibition in neurological and psychiatric disorders.
Saved in:
| Title: | GlyT1 (SLC6A9) inhibition in neurological and psychiatric disorders. |
|---|---|
| Authors: | Cavalcante DP; Department of Pharmacology, Institute of Biological Sciences, Federal University of Goiás, Goiânia, GO, Brazil., Carvalho GA; Department of Pharmacology, Institute of Biological Sciences, Federal University of Goiás, Goiânia, GO, Brazil., Nunes AÍS; Department of Pharmacology, Institute of Biological Sciences, Federal University of Goiás, Goiânia, GO, Brazil., Quintanilha AR; Department of Pharmacology, Institute of Biological Sciences, Federal University of Goiás, Goiânia, GO, Brazil., Nascimento LRC; Department of Pharmacology, Institute of Biological Sciences, Federal University of Goiás, Goiânia, GO, Brazil., Caixeta L; School of Medicine, Federal University of Goiás, Goiânia, GO, Brazil., Ulrich H; Institute of Chemistry, University of São Paulo, São Paulo, SP, Brazil., Gomez RS; School of Medicine, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil., Pinto MCX; Department of Pharmacology, Institute of Biological Sciences, Federal University of Goiás, Goiânia, GO, Brazil. pintomcx@ufg.br. |
| Source: | Naunyn-Schmiedeberg's archives of pharmacology [Naunyn Schmiedebergs Arch Pharmacol] 2026 Apr 14. Date of Electronic Publication: 2026 Apr 14. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0326264 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1912 (Electronic) Linking ISSN: 00281298 NLM ISO Abbreviation: Naunyn Schmiedebergs Arch Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
